The role of maintenance therapy in eosinophilic esophagitis: who, why, and how?
Author:
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology
Link
http://link.springer.com/article/10.1007/s00535-017-1397-z/fulltext.html
Reference61 articles.
1. Rothenberg ME. Molecular, genetic, and cellular bases for treating eosinophilic esophagitis. Gastroenterology. 2015;148(6):1143–57. doi: 10.1053/j.gastro.2015.02.002 .
2. Philpott H, Nandurkar S, Thien F, et al. Eosinophilic esophagitis: a clinicopathological review. Pharmacol Ther. 2015;146:12–22. doi: 10.1016/j.pharmthera.2014.09.001 .
3. Dellon ES, Liacouras CA. Advances in clinical management of eosinophilic esophagitis. Gastroenterology. 2014;147(6):1238–54. doi: 10.1053/j.gastro.2014.07.055 .
4. Dellon ES, Gonsalves N, Hirano I, Liacouras CA, Katzka DA, et al. ACG clinical guideline: evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE). Am J Gastroenterol. 2013;108(5):679–92. doi: 10.1038/ajg.2013.71 (quiz 93).
5. Lucendo AJ, Arias A, Gonzalez-Cervera J, et al. Dual response to dietary/topical steroid and proton pump inhibitor therapy in adult patients with eosinophilic esophagitis. J Allergy Clin Immunol. 2016;137(3):931–4 e2. doi: 10.1016/j.jaci.2015.07.033 .
Cited by 34 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Relationship Between Eosinophilic Esophagitis and Immunotherapy;Immunology and Allergy Clinics of North America;2024-05
2. Improved Outcomes in Eosinophilic Esophagitis with Higher Medication Possession Ratio;Medicines;2024-03-26
3. Efficacy and safety of dupilumab up to 52 weeks in adults and adolescents with eosinophilic oesophagitis (LIBERTY EoE TREET study): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial;The Lancet Gastroenterology & Hepatology;2023-11
4. Recent Advances in the Treatment of Eosinophilic Esophagitis;The Journal of Allergy and Clinical Immunology: In Practice;2023-09
5. Food elimination diet is a viable alternative therapy for eosinophilic esophagitis responsive to proton pump inhibitors;BMC Gastroenterology;2023-03-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3